Genomics and pharmacogenomics of salt-sensitive hypertension

Current Hypertension Reviews

Volumn 11, Issue 1, 2015, Pages 49-56

  Armando, Ines ^a   Villar, Van Anthony M ^a   Jose, Pedro A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Kidney; Pharmacogenomics; Salt sensitivity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE SYNTHASE; ALPHA ADDUCIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ B2 RECEPTOR; BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE; CHLORIDE CHANNEL; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; CYTOCHROME P450 3A5; DIMETHYLARGININASE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; EPITHELIAL SODIUM CHANNEL; FIBROBLAST GROWTH FACTOR 5; G PROTEIN COUPLED RECEPTOR KINASE 4; GUANINE NUCLEOTIDE BINDING PROTEIN; NATRIURETIC FACTOR; PROTEIN KINASE WNK1; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA BINDING PROTEIN 2; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CALCIUM EXCHANGE PROTEIN; TAMM HORSFALL GLYCOPROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VON WILLEBRAND FACTOR; SODIUM INTAKE;

ADRENERGIC SYSTEM; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; DNA POLYMORPHISM; DOPAMINERGIC SYSTEM; ELECTROLYTE BALANCE; GENE INTERACTION; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; OXIDATIVE STRESS; PHARMACOGENOMICS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SODIUM TRANSPORT; VASCULAR SMOOTH MUSCLE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC VARIATION; GENETICS; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHARMACOLOGY; PHYSIOLOGY; SODIUM INTAKE;

BLOOD PRESSURE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; HYPERTENSION; KIDNEY; POLYMORPHISM, GENETIC; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; SODIUM, DIETARY;

EID: 84934767059     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/1573402111999150521102331     Document Type: Article

References (82)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
2. Franco V, Oparil S. Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr 2006; 25: 247S-55.
3. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: metaanalysis of prospective studies. BMJ 2009; 339: b4567.
4. He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis 2010; 52: 363-82.
5. Sanada H, Jones JE, Jose PA. Genetics of salt-sensitive hypertension. Curr Hypertens Rep 2011; 13: 55-66.
6. Kanbay M, Chen Y, Solak Y, Sanders PW. Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens 2011; 20: 37-43.
7. Rettig R, Bandelow N, Patschan O, Kuttler B, Frey B, Uber A. The importance of the kidney in primary hypertension: insights from cross-transplantation. J Hum Hypertens 1996; 10: 641-4.
8. Strazzullo P, Galletti F. Genetics of salt-sensitive hypertension. Curr Hypertens Rep 2007; 9: 25-32.
9. Hall JE, Granger JP, do Carmo JM, et al. Hypertension: physiology and pathophysiology. Compr Physiol 2012; 2: 2393-442.
10. Navar LG, Prieto MC, Satou R, Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 2011; 11: 180-6.
11. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11: 197-200.
12. Osborn JW, Fink GD, Kuroki MT. Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation. Curr Hypertens Rep 2011; 13: 221-8.
13. Zhang MZ, Harris RC. Antihypertensive mechanisms of intra-renal dopamine. Curr Opin Nephrol Hypertens 2015; 24: 117-22.
14. Zeng C, Jose PA. Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension 2011; 57: 11-7.
15. Banday AA, Lokhandwala MF. Inhibition of natriuretic factors increases blood pressure in rats. Am J Physiol Renal Physiol 2009; 297: F397-402.
16. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-87.
17. Williams JS, Chamarthi B, Goodarzi MO, et al. Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens 2012; 25: 812-7.
18. Garza AE, Rariy CM, Sun B, et al. Variants in striatin gene are associated with salt-sensitive blood pressure in mice and humans. Hypertension 2015; 65: 211-7.
19. Carey RM, Schoeffel CD, Gildea JJ, et al. Salt sensitivity of blood pressure is associated with polymorphisms in the sodiumbicarbonate cotransporter. Hypertension 2012; 60: 1359-66.
20. Padmanabhan S, Melander O, Johnson T, et al. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 2010; 6: e1001177.
21. Trudu M, Janas S, Lanzani C, et al. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med 2013; 19: 1655-60.
22. Bengra C, Mifflin TE, Khripin Y, et al. Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem 2002; 48: 2131-40.
23. Speirs HJ, Katyk K, Kumar NN, Benjafield AV, Wang WY, Morris BJ. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004; 22: 931-6.
24. Sanada H, Yatabe J, Midorikawa S, et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006; 52: 352-60.
25. Gu D, Su S, Ge D, et al. Association study with 33 singlenucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 2006; 47: 1147-54.
26. Lohmueller KE, Wong LJ, Mauney MM, et al. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann Hum Genet 2006; 70: 27-41.
27. Lee M, Kim MK, Kim SM, Park H, Park CG, Park HK. Genderbased differences on the association between salt-sensitive genes and obesity in Korean children aged between 8 and 9 years. PLoS One 2015; 10: e0120111.
28. Giacomini KM, Yee SW, Ratain MJ, Weinshilboum RM, Kamatani N, Nakamura Y. Pharmacogenomics and patient care: one size does not fit all. Sci Transl Med 2012; 4: 153ps18.
29. Beeks E, Kessels AG, Kroon AA, et al. Genetic predisposition to salt-sensitivity: a systematic review. J Hypertens 2004; 22: 1243-9.
30. Hunt SC, Geleijnse JM, Wu LL, Witteman JC, Williams RR, Grobbee DE. Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene. Am J Hypertens 1999; 12: 460-6.
31. Li Y, Yang P, Wu S, et al. Gender-specific association between ACE gene I/D polymorphism and blood pressure response to hydrochlorothiazide in Han Chinese hypertensive patients. Biochem Genet 2011; 49: 704-14.
32. Li Y, Zhou Y, Yang P, et al. Interaction of ACE and CYP11B2 genes on blood pressure response to hydrochlorothiazide in Han Chinese hypertensive patients. Clin Exp Hypertens 2011; 33: 141-6.
33. Konoshita T1; Genomic Disease Outcome Consortium (G-DOC) Study Investigators. Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system. Curr Hypertens Rep 2011; 13: 356-61.
34. Zhao Q, Gu D, Hixson JE, et al. Common variants in epithelial sodium channel genes contribute to salt sensitivity of blood pressure: The GenSalt study. Circ Cardiovasc Genet 2011; 4: 375-80.
35. Luo F, Wang Y, Wang X, Sun K, Zhou X, Hui R. A functional variant of NEDD4L is associated with hypertension, antihypertensive response, and orthostatic hypotension. Hypertension 2009; 54: 796-801.
36. Svensson-Farbom P, Wahlstrand B, Almgren P, Dahlberg J, Fava C, Kjeldsen S. A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients. J Hypertens 2011; 29: 388-95.
37. McDonough CW, Burbage SE, Duarte JD, et al. Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics. J Hypertens 2013; 31: 698-704.
38. Donner KM, Hiltunen TP, Hannila-Handelberg T, Suonsyrja T, Kontula K. STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men. Hypertens Res 2012; 35: 107-14.
39. Duarte JD, Lobmeyer MT, Wang Z, Chapman AB, Gums JG, Langaee TY. Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazide. Pharmacogenet Genomics 2010; 20: 516-9.
40. San-Cristobal P, Pacheco-Alvarez D, Richardson C, et al. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway. Proc Natl Acad Sci U S A 2009; 106: 4384-9.
41. Filigheddu F, Argiolas G, Degortes S, et al. Haplotypes of the adrenergic system predict the blood pressure response to betablockers in women with essential hypertension. Pharmacogenomics 2010; 11: 319-25.
42. Liu K, Liu J, Huang Y, et al. Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls. PLoS One 2010; pii: e13057.
43. Lanzani C, Citterio L, Glorioso N, et al. Adducin-and ouabainrelated gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies. Sci Transl Med 2010; 2: 59ra87.
44. Staessen JA, Thijs L, Stolarz-Skrzypek K, et al. Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin. Trials 2011; 12: 13.
45. Manunta P, Lavery G, Lanzani C, et al. Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation. Hypertension 2008; 52: 366-72.
46. Turner ST, Bailey KR, Schwartz GL, Chapman AB, Chai HS, Boerwinkle E. Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker. Hypertension 2012; 59: 1204-11.
47. Jose PA, Soares-da-Silva P, Eisner GM, Felder RA. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 2010; 1802: 1259-66.
48. Liu C, Xi B. Pooled analyses of the associations of polymorphisms in the GRK4 and EMILIN1 genes with hypertension risk. Int J Med Sci 2012; 9: 274-9.
49. Bhatnagar V, O'Connor DT, Brophy VH, et al. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens 2009; 22: 332-8.
50. Vandell AG, Lobmeyer MT, Gawronski BE, et al. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension. Hypertension 2012; 60: 957-64.
51. Rayner B, Ramesar R, Steyn K, Levitt N, Lombard C, Charlton K. G-protein-coupled receptor kinase 4 polymorphisms predict blood pressure response to dietary modification in Black patients with mild-to-moderate hypertension. J Hum Hypertens 2012; 26: 334-9.
52. Wagner F, Malice MP, Wiegert E, McGrath HE, Gildea J, Mitta S. A comparison of the natriuretic and kaliuretic effects of cicletanine and hydrochlorothiazide in prehypertensive and hypertensive humans. J Hypertens 2012; 30: 819-27.
53. Sanada H, Yoneda M, Yatabe J, et al. Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade. Pharmacogenomics J 2015. [Epub ahead of print].
54. Norat T, Bowman R, Luben R, et al. Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study. Am J Clin Nutr 2008; 88: 392-6.
55. Gu D, Kelly TN, Hixson JE, Chen J, Liu D, Chen JC. Genetic variants in the renin-angiotensin-aldosterone system and salt sensitivity of blood pressure. J Hypertens 2010; 28: 1210-20.
56. Iwai N, Kajimoto K, Tomoike H, Takashima N. Polymorphism of CYP11B2 determines salt sensitivity in Japanese. Hypertension 2007; 49: 825-31.
57. Tang W, Wu H, Zhou X, et al. Association of the C-344T polymorphism of CYP11B2 gene with essential hypertension in Hani and Yi minorities of China. Clin Chim Acta 2006; 364: 222-5.
58. Alikhani-Koupaei R, Fouladkou F, Fustier P, et al. Identification of polymorphisms in the human11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity. FASEB J 2007; 21: 3618-28.
59. Pojoga L, Kolatkar NS, Williams JS, Perlstein TS, Jeunemaitre X, Brown NJ. Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension 2006; 48: 892-900.
60. Barlassina C, Dal Fiume C, Lanzani C, et al. Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension. Hum Mol Genet 2007; 16: 1630-8.
61. Dahlberg J, Nilsson LO, von Wowern F, Melander O. Polymorphism in NEDD4L is associated with increased salt sensitivity, reduced levels of P-renin and increased levels of NtproANP. PLoS One 2007; 2: e432.
62. Li C, Yang X, He J, et al. A gene-based analysis of variants in the serum/glucocorticoid regulated kinase (SGK) genes with blood pressure responses to sodium intake: the GenSalt Study. PLoS One 2014; 9: e98432.
63. Rao AD, Sun B, Saxena A, et al. Polymorphisms in the serum-and glucocorticoid-inducible kinase 1 gene are associated with blood pressure and renin response to dietary salt intake. J Hum Hypertens 2013; 27: 176-80.
64. Wang Y, O'Connell JR, McArdle PF, et al. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106: 226-31.
65. Adeyemo A, Gerry N, Chen G, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009; 5: e1000564.
66. Fava C, Danese E, Montagnana M, et al. Serine/threonine kinase 39 is a candidate gene for primary hypertension especially in women: results from two cohort studies in Swedes. J Hypertens 2011; 29: 484-91.
67. Rhee MY, Yang SJ, Oh SW, et al. Novel genetic variations associated with salt sensitivity in the Korean population. Hypertens Res 2011; 34: 606-11.
68. Eap CB, Bochud M, Elston RC, et al. CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt. Hypertension 2007; 49: 1007-14.
69. Bagos PG, Elefsinioti AL, Nikolopoulos GK, Hamodrakas SJ. The GNB3 C825T polymorphism and essential hypertension: a metaanalysis of 34 studies including 14, 094 cases and 17, 760 controls. J Hypertens 2007; 25: 487-500.
70. Citterio L, Simonini M, Zagato L, et al. Genes involved in vasoconstriction and vasodilation system affect salt-sensitive hypertension. PLoS One 2011; 6: e19620.
71. Gu D, Zhao Q, Kelly TN, et al. The role of the kallikrein-kinin system genes in the salt sensitivity of blood pressure: the GenSalt Study. Am J Epidemiol 2012; 176: S72-80.
72. Schreiber R, Bellinazzi VR, Sposito AC, et al. Influence of the C242T polymorphism of the p22-phox gene (CYBA) on the interaction between urinary sodium excretion and blood pressure in an urban Brazilian population. PLoS One 2013; 8: e81054.
73. Castejon AM, Bracero J, Hoffmann IS, Alfieri AB, Cubeddu LX. NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2006; 20: 772-9.
74. Wang R, Zhong B, Liu Y, Wang C. Association between alphaadducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis. J Appl Genet 2010; 51: 87-94.
75. Miyaki K, Tohyama S, Murata M, et al. Salt intake affects the relation between hypertension and the T-786 C polymorphism in the endothelial nitric oxide synthase gene. Am J Hypertens 2005; 18: 1556-62.
76. Dengel DR, Brown MD, Ferrell RE, Reynolds TH, Supiano MA. A preliminary study on T-786 C endothelial nitric oxide synthase gene and renal hemodynamic and blood pressure responses to dietary sodium. Physiol Res 2007; 56: 393-401.
77. Defago MD, Gu D, Hixson JE, et al. Common genetic variants in the endothelial system predict blood pressure response to sodium intake: the GenSalt study. Am J Hypertens 2013; 26: 643-56.
78. Williams JS, Hopkins PN, Jeunemaitre X, Brown NJ. CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow. J Hypertens 2011; 29: 1913-8.
79. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de La Sierra A. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001; 38: 1204-9.
80. Caprioli J, Mele C, Mossali C, Gallizioli L, Giacchetti G, Noris M, Remuzzi G, Benigni A. Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension. Can J Physiol Pharmacol 2008; 86: 505-51.
81. Wang JG, Liu L, Zagato L, et al. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens 2004; 22: 937-44.
82. Williams SM, Ritchie MD, Phillips JA 3rd, et al. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered. 2004; 57: 28-38.